HHCN Capital + Strategy: The Factors Affecting Home-Based Care M&A in 2023
Home Health Care
MAY 3, 2023
The discussion took place on March 30, 2023 during HHCN Capital + Strategy in Washington D.C. We’re seeing, and this is just based on our current transaction activity, that competition is fierce for quality companies that have an EBITDA of between $750,000 and $5M. The 2023 headlines are from 2022.
83 
Let's personalize your content